Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuichi Hayashi

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Annals of Surgical Oncology|February 21, 2014
Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma: incidence and treatment outcomeAkihiro Homma, Ryuichi Hayashi, Kazuto Matsuura, et al.
DEN Open|July 6, 2023
Alcohol consumption, multiple Lugol-voiding lesions, and field cancerizationChikatoshi Katada, Tetsuji Yokoyama, Tomonori Yano, et al.
Auris, Nasus, Larynx|March 23, 2017
Japanese Clinical Practice Guideline for Head and Neck CancerKen-Ichi Nibu, Ryuichi Hayashi, Takahiro Asakage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2022
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled TrialNaomi Kiyota, Makoto Tahara, Junki Mizusawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck CancerMakoto Tahara, Naomi Kiyota, Takeshi Kodaira, et al.
Oral Oncology|August 7, 2024
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008Hidetoshi Shimizu, Takeshi Kodaira, Naomi Kiyota, et al.
Auris, Nasus, Larynx|January 21, 2026
Transoral surgery for hypopharyngeal and laryngeal cancers in Japan: Current status from a nationwide multicenter retrospective studyKoji Araki, Seiichi Yoshimoto, Takashi Fujii, et al.
Cancer Medicine|May 15, 2021
Transoral surgery for superficial head and neck cancer: National Multi-Center Survey in JapanChikatoshi Katada, Manabu Muto, Satoshi Fujii, et al.
Cancer|July 11, 2020
Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of JapanYuki Saito, Ryuichi Hayashi, Yoshiyuki Iida, et al.
Frontiers in Immunology|August 13, 2024
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinomaTakahiro Tsujikawa, Kazuchika Ohno, Kei-Ichi Morita, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Annals of Surgical Oncology|February 21, 2014
Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma: incidence and treatment outcomeAkihiro Homma, Ryuichi Hayashi, Kazuto Matsuura, et al.
DEN Open|July 6, 2023
Alcohol consumption, multiple Lugol-voiding lesions, and field cancerizationChikatoshi Katada, Tetsuji Yokoyama, Tomonori Yano, et al.
Auris, Nasus, Larynx|March 23, 2017
Japanese Clinical Practice Guideline for Head and Neck CancerKen-Ichi Nibu, Ryuichi Hayashi, Takahiro Asakage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2022
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled TrialNaomi Kiyota, Makoto Tahara, Junki Mizusawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck CancerMakoto Tahara, Naomi Kiyota, Takeshi Kodaira, et al.
Oral Oncology|August 7, 2024
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008Hidetoshi Shimizu, Takeshi Kodaira, Naomi Kiyota, et al.
Auris, Nasus, Larynx|January 21, 2026
Transoral surgery for hypopharyngeal and laryngeal cancers in Japan: Current status from a nationwide multicenter retrospective studyKoji Araki, Seiichi Yoshimoto, Takashi Fujii, et al.
Cancer Medicine|May 15, 2021
Transoral surgery for superficial head and neck cancer: National Multi-Center Survey in JapanChikatoshi Katada, Manabu Muto, Satoshi Fujii, et al.
Cancer|July 11, 2020
Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of JapanYuki Saito, Ryuichi Hayashi, Yoshiyuki Iida, et al.
Frontiers in Immunology|August 13, 2024
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinomaTakahiro Tsujikawa, Kazuchika Ohno, Kei-Ichi Morita, et al.
Pageof 19